“…However, a growing body of evidence (Besant & Attwood, ; Fan et al , ; Fraczyk et al , ; Fuhs et al , ; Shen et al , ; Wieland & Attwood, ; Panda et al , ; Srivastava et al , ; Xu et al , ,b; Fuhs & Hunter, ) indicates that phosphorylation of other amino acids, termed here “non‐canonical” phosphorylation, including His, Asp, Glu, Lys, Arg and Cys [in addition to pyrophosphorylation of Ser and Thr to form ppSer and ppThr (Chanduri et al , ; Harmel & Fiedler, ), and Lys polyphosphorylation (Bentley‐DeSousa & Downey, )], may also regulate protein signalling functions. Of note, the generation of both site‐specific and generic antibodies against phosphohistidine (pHis) (Kee et al , , ; Fuhs et al , ; Lilley et al , ) has recently allowed mammalian cell‐type independent roles for this PTM to be elucidated (Fuhs et al , ) in processes as diverse as ion channel regulation (Srivastava et al , ) and T‐cell signalling (Panda et al , ), and during cell proliferation, differentiation and migration. In contrast, and despite occasional reports in the literature (Besant et al , ; Attwood et al , ), the prevalence (or otherwise) of other non‐canonical protein phosphorylation events has not been reliably confirmed in human cells, and so specific information about the extent and details of the sites of modification is lacking.…”